A carregar...
A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis
BACKGROUND: The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value. It is a key chemokine driving the formation of lymphoid follicles within the inflamed synovium. T...
Na minha lista:
| Publicado no: | BMC Rheumatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7604968/ https://ncbi.nlm.nih.gov/pubmed/33292827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41927-020-00154-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|